Kearny Financial Corp
5 nominees · 3 ballot items.
Election of five directors; ratification of Crowe LLP as independent auditor; advisory Say-on-Pay on executive compensation; Board recommends voting FOR all proposals.
Follow how the vote landed and what changed on Kearny Financial Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Directors
ManagementBoard: FORElection of five directors to the Board of Directors.
- 2
Ratification of Appointment of Independent Auditor
ManagementBoard: FORRatification of Crowe LLP as the Company's independent registered public accounting firm for the year ending June 30, 2026.
- 3
Advisory Vote on Executive Compensation
ManagementBoard: FORAdvisory, non-binding vote to approve executive compensation as described in this Proxy Statement.
Nominees on the ballot5
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | DIMENSIONAL FUND ADVISORS LP | 4.8% | 3,085,703 | $23M |
| 2 | BlackRock, Inc. | 4.5% | 2,922,399 | $22M |
| 3 | T. Rowe Price Investment Management, Inc. | 4.1% | 2,645,142 | $20M |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 4.1% | 2,632,416 | $20M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 3.8% | 2,441,072 | $18M |
| 6 | BlackRock, Inc. | 3.4% | 2,193,177 | $17M |
| 7 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 3.4% | 2,175,997 | $16M |
| 8 | AQR CAPITAL MANAGEMENT LLC | 3.0% | 1,949,315 | $15M |
| 9 | STATE STREET CORP | 2.9% | 1,868,591 | $14M |
| 10 | TWO SIGMA INVESTMENTS, LP | 2.5% | 1,625,685 | $12M |
Other Financial Services sector meetings6
Upcoming shareholder meetings at Kearny Financial Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Kearny Financial Corp 2025 annual meeting?
- Kearny Financial Corp (KRNY) holds its 2025 annual shareholder meeting on Tuesday, October 21, 2025.
- What is the record date for the Kearny Financial Corp 2025 meeting?
- The record date for the Kearny Financial Corp 2025 meeting is Friday, August 22, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Kearny Financial Corp's 2025 meeting?
- The board is presenting 5 director nominees at the Kearny Financial Corp 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Kearny Financial Corp 2025 meeting?
- Shareholders will vote on 3 proposals at the Kearny Financial Corp 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.